Twist Bioscience internally-discovered single domain antibody TB202-3 shows potent binding to multiple strains of SARS-CoV-2, including alpha, beta, and gamma strains, in preclinical studies
TB202-3 binds to a specific area of the SARS-CoV-2 spike protein that has not been impacted by most viral mutations, making it an important candidate for clinical testing. The antibody demonstrates potency against multiple strains of COVID-19, including those with various mutations.